A Combination of UTMD-Mediated HIF-1α shRNA Transfection and TAE in the Treatment of Hepatic Cancer

Figure 3

The change of tumor size by CEUS in four groups at day 14. (a) Control group; (b) UTMD group; (c) TAE group; (d) UTMD+TAE group. ☆ indicates the location of the tumor.

(a)

(b)

(c)

(d)